Cargando…

Probabilistic drug connectivity mapping

BACKGROUND: The aim of connectivity mapping is to match drugs using drug-treatment gene expression profiles from multiple cell lines. This can be viewed as an information retrieval task, with the goal of finding the most relevant profiles for a given query drug. We infer the relevance for retrieval...

Descripción completa

Detalles Bibliográficos
Autores principales: Parkkinen, Juuso A, Kaski, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011783/
https://www.ncbi.nlm.nih.gov/pubmed/24742351
http://dx.doi.org/10.1186/1471-2105-15-113
_version_ 1782314844355035136
author Parkkinen, Juuso A
Kaski, Samuel
author_facet Parkkinen, Juuso A
Kaski, Samuel
author_sort Parkkinen, Juuso A
collection PubMed
description BACKGROUND: The aim of connectivity mapping is to match drugs using drug-treatment gene expression profiles from multiple cell lines. This can be viewed as an information retrieval task, with the goal of finding the most relevant profiles for a given query drug. We infer the relevance for retrieval by data-driven probabilistic modeling of the drug responses, resulting in probabilistic connectivity mapping, and further consider the available cell lines as different data sources. We use a special type of probabilistic model to separate what is shared and specific between the sources, in contrast to earlier connectivity mapping methods that have intentionally aggregated all available data, neglecting information about the differences between the cell lines. RESULTS: We show that the probabilistic multi-source connectivity mapping method is superior to alternatives in finding functionally and chemically similar drugs from the Connectivity Map data set. We also demonstrate that an extension of the method is capable of retrieving combinations of drugs that match different relevant parts of the query drug response profile. CONCLUSIONS: The probabilistic modeling-based connectivity mapping method provides a promising alternative to earlier methods. Principled integration of data from different cell lines helps to identify relevant responses for specific drug repositioning applications.
format Online
Article
Text
id pubmed-4011783
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40117832014-05-20 Probabilistic drug connectivity mapping Parkkinen, Juuso A Kaski, Samuel BMC Bioinformatics Methodology Article BACKGROUND: The aim of connectivity mapping is to match drugs using drug-treatment gene expression profiles from multiple cell lines. This can be viewed as an information retrieval task, with the goal of finding the most relevant profiles for a given query drug. We infer the relevance for retrieval by data-driven probabilistic modeling of the drug responses, resulting in probabilistic connectivity mapping, and further consider the available cell lines as different data sources. We use a special type of probabilistic model to separate what is shared and specific between the sources, in contrast to earlier connectivity mapping methods that have intentionally aggregated all available data, neglecting information about the differences between the cell lines. RESULTS: We show that the probabilistic multi-source connectivity mapping method is superior to alternatives in finding functionally and chemically similar drugs from the Connectivity Map data set. We also demonstrate that an extension of the method is capable of retrieving combinations of drugs that match different relevant parts of the query drug response profile. CONCLUSIONS: The probabilistic modeling-based connectivity mapping method provides a promising alternative to earlier methods. Principled integration of data from different cell lines helps to identify relevant responses for specific drug repositioning applications. BioMed Central 2014-04-17 /pmc/articles/PMC4011783/ /pubmed/24742351 http://dx.doi.org/10.1186/1471-2105-15-113 Text en Copyright © 2014 Parkkinen and Kaski; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology Article
Parkkinen, Juuso A
Kaski, Samuel
Probabilistic drug connectivity mapping
title Probabilistic drug connectivity mapping
title_full Probabilistic drug connectivity mapping
title_fullStr Probabilistic drug connectivity mapping
title_full_unstemmed Probabilistic drug connectivity mapping
title_short Probabilistic drug connectivity mapping
title_sort probabilistic drug connectivity mapping
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011783/
https://www.ncbi.nlm.nih.gov/pubmed/24742351
http://dx.doi.org/10.1186/1471-2105-15-113
work_keys_str_mv AT parkkinenjuusoa probabilisticdrugconnectivitymapping
AT kaskisamuel probabilisticdrugconnectivitymapping